{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T12:41:24Z","timestamp":1773405684583,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.eururo.2013.05.033","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T13:30:25Z","timestamp":1369229425000},"page":"191-199","source":"Crossref","is-referenced-by-count":91,"title":["The Role of Radical Prostatectomy and Lymph Node Dissection in Lymph Node\u2013Positive Prostate Cancer: A Systematic Review of the Literature"],"prefix":"10.1016","volume":"66","author":[{"given":"Georgios","family":"Gakis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Joniau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guram","family":"Karazanashvili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agostino","family":"Mattei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manfred","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian G.","family":"Stief","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2013.05.033_bib0005","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2010.05.027","article-title":"Does local treatment of the prostate in advanced and\/or lymph node metastatic disease improve efficacy of androgen-deprivation therapy? A systematic review","volume":"58","author":"Verhagen","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0010","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000480794","article-title":"Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis","volume":"32","author":"Gerber","year":"1997","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2013.05.033_bib0020","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1056\/NEJMoa040720","article-title":"Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer","volume":"351","author":"Tannock","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2013.05.033_bib0025","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00120-009-1940-5","article-title":"Secondary hormonal ablation in hormone-independent prostate cancer [in German]","volume":"48","author":"Schilling","year":"2009","journal-title":"Urologe A"},{"key":"10.1016\/j.eururo.2013.05.033_bib0030","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/S0302-2838(02)00134-3","article-title":"Clinical outcome of patients with lymph node positive prostate cancer after radical prostatectomy versus androgen deprivation","volume":"41","author":"Grimm","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0035","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.eururo.2009.12.034","article-title":"Survival benefit of radical prostatectomy in lymph node-positive patients with prostate cancer","volume":"57","author":"Engel","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0040","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0022-5347(01)61640-9","article-title":"Radical retropubic prostatectomy plus orchiectomy versus orchiectomy alone for pTxN+ prostate cancer: a matched comparison","volume":"161","author":"Ghavamian","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0045","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.eururo.2012.08.009","article-title":"ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder","volume":"63","author":"Gakis","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0050","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2013.05.033_bib0055","unstructured":"Oxford Centre for Evidence-based Medicine (CEBM) levels of evidence. CEBM Web site. www.cebm.net. Updated May 2009."},{"key":"10.1016\/j.eururo.2013.05.033_bib0060","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0140-6736(01)06103-7","article-title":"Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial","volume":"358","author":"Mickisch","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2013.05.033_bib0065","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007565.pub2","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.eururo.2013.05.033_bib0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0090-4295(97)00186-6","article-title":"Stage D1 (T1-3, N1-3, M0) prostate cancer: a case-controlled comparison of conservative treatment versus radical prostatectomy","volume":"50","author":"Cadeddu","year":"1997","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.05.033_bib0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000475161","article-title":"Survival and quality of life of patients with stage D1 (T1-3 pN1-2 M0) prostate cancer. Radical prostatectomy plus androgen deprivation versus androgen deprivation alone","volume":"27","author":"Frohm\u00fcller","year":"1995","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0080","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/1097-0142(20010101)91:1<66::AID-CNCR9>3.0.CO;2-P","article-title":"Risk of prostate carcinoma death in patients with lymph node metastasis","volume":"91","author":"Cheng","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.eururo.2013.05.033_bib0085","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1111\/j.1464-410X.2010.09730.x","article-title":"Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study","volume":"107","author":"Steuber","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0090","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/01.ju.0000049032.38743.c7","article-title":"Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure?","volume":"169","author":"Bader","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0095","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3109\/00365599.2011.637956","article-title":"Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors","volume":"46","author":"Joniau","year":"2012","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0100","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1464-410X.2010.09402.x","article-title":"Intraoperative frozen section assessment of pelvic lymph nodes during radical prostatectomy is of limited value","volume":"106","author":"Song","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.juro.2010.03.039","article-title":"Predicting biochemical recurrence-free survival for patients with positive pelvic lymph nodes at radical prostatectomy","volume":"184","author":"von Bodman","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0110","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/PPO.0b013e31824672e1","article-title":"Improvement in prostate cancer survival over time: a 20-year analysis: the Will Rogers phenomenon returns","volume":"18","author":"Lee","year":"2012","journal-title":"Cancer J"},{"key":"10.1016\/j.eururo.2013.05.033_bib0115","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2013.05.033_bib0120","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2006.05.045","article-title":"A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer","volume":"51","author":"Briganti","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0125","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0022-5347(05)65177-4","article-title":"Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis","volume":"167","author":"Heidenreich","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0130","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jss.2012.06.069","article-title":"Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study","volume":"178","author":"Ji","year":"2012","journal-title":"J Surg Res"},{"key":"10.1016\/j.eururo.2013.05.033_bib0135","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.juro.2012.01.079","article-title":"Pelvic lymph node dissection for prostate cancer: frequency and distribution of nodal metastases in a contemporary radical prostatectomy series","volume":"187","author":"Godoy","year":"2012","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/pros.21420","article-title":"Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum","volume":"72","author":"Briganti","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2013.05.033_bib0145","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0022-5347(17)56906-2","article-title":"Extended pelvic lymphadenectomy for prostatic cancer","volume":"121","author":"Golimbu","year":"1979","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0150","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.eururo.2012.06.057","article-title":"Mapping of pelvic lymph node metastases in prostate cancer","volume":"63","author":"Joniau","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0155","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2007.07.035","article-title":"The template of the primary lymphatic landing sites of the prostate should be revisited: results of a multimodality mapping study","volume":"53","author":"Mattei","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0160","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.eururo.2007.01.050","article-title":"Detection rate and operating time required for \u03b3 probe-guided sentinel lymph node resection after injection of technetium-99m nanocolloid into the prostate with and without preoperative imaging","volume":"52","author":"Warncke","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0165","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.eururo.2006.08.049","article-title":"Limitations of radioguided surgery in high-risk prostate cancer","volume":"51","author":"Weckermann","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0170","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.eururo.2011.07.060","article-title":"Pelvic\/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography\/computed tomography","volume":"60","author":"Rigatti","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0175","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1002\/pros.21145","article-title":"Quantification of tumor cell burden by analysis of single cell lymph node disaggregates in metastatic prostate cancer","volume":"70","author":"Schilling","year":"2010","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2013.05.033_bib0180","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/j.eururo.2011.11.008","article-title":"Performance characteristics of computed tomography in detecting lymph node metastases in contemporary patients with prostate cancer treated with extended pelvic lymph node dissection","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eururo.2011.01.015","article-title":"Prospective evaluation of 11C-choline positron emission tomography\/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases","volume":"60","author":"Budiharto","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0190","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1148\/radiol.09090413","article-title":"18F choline PET\/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients","volume":"254","author":"Beheshti","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.eururo.2013.05.033_bib0195","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejca.2009.11.008","article-title":"[F(18)]-fluoroethylcholine combined in-line PET-CT scan for detection of lymph-node metastasis in high risk prostate cancer patients prior to radical prostatectomy: preliminary results from a prospective histology-based study","volume":"46","author":"Steuber","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2013.05.033_bib0200","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.eururo.2012.08.003","article-title":"18F-fluoroethylcholine PET\/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent","volume":"63","author":"Tilki","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0205","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.urology.2012.05.050","article-title":"Visualisation of the lymph node pathway in real time by laparoscopic radioisotope- and fluorescence-guided sentinel lymph node dissection in prostate cancer staging","volume":"80","author":"Jeschke","year":"2012","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.05.033_bib0210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00345-010-0533-7","article-title":"Modified concept for radioisotope-guided sentinel lymph node dissection in prostate cancer","volume":"28","author":"Schilling","year":"2010","journal-title":"World J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0215","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ejca.2012.09.034","article-title":"Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and\/or prostate cancer","volume":"49","author":"Triantafyllou","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.eururo.2013.05.033_bib0220","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.eururo.2008.12.034","article-title":"Combined ultrasmall superparamagnetic particles of iron oxide-enhanced and diffusion-weighted magnetic resonance imaging reliably detect pelvic lymph node metastases in normal-sized nodes of bladder and prostate cancer patients","volume":"55","author":"Thoeny","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0225","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.eururo.2012.01.050","article-title":"Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and factoring in tertiary grades","volume":"61","author":"Epstein","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0230","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1464-410X.2012.11324.x","article-title":"An updated prostate cancer staging nomogram (Partin tables) based on cases from 2006 to 2011","volume":"111","author":"Eifler","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0235","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2011.10.044","article-title":"Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores","volume":"61","author":"Briganti","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0240","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.eururo.2007.01.108","article-title":"Percentage of positive biopsy cores can improve the ability to predict lymph node invasion in patients undergoing radical prostatectomy and extended pelvic lymph node dissection","volume":"51","author":"Briganti","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0350","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/pros.22559","article-title":"External validation of the updated Briganti nomogram to predict lymph node invasion in prostate cancer patients undergoing extended lymph node dissection","volume":"73","author":"Hansen","year":"2013","journal-title":"Prostate"},{"key":"10.1016\/j.eururo.2013.05.033_bib0250","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1464-410X.2010.09485.x","article-title":"Percentage of positive biopsies predicts lymph node involvement in men with low-risk prostate cancer undergoing radical prostatectomy and extended pelvic lymphadenectomy","volume":"107","author":"Heidenreich","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0255","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1442-2042.2012.02993.x","article-title":"Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer","volume":"19","author":"Abdollah","year":"2012","journal-title":"Int J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.eururo.2008.09.043","volume":"55","author":"Briganti","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0265","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.eururo.2008.05.023","article-title":"Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy","volume":"54","author":"Schumacher","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0270","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/j.1743-6109.2012.02812.x","article-title":"Extended pelvic lymph node dissection does not affect erectile function recovery in patients treated with bilateral nerve-sparing radical prostatectomy","volume":"9","author":"Gandaglia","year":"2012","journal-title":"J Sex Med"},{"key":"10.1016\/j.eururo.2013.05.033_bib0275","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/j.1464-410X.2011.10204.x","article-title":"Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy","volume":"108","author":"Abdollah","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ctrv.2008.08.002","article-title":"A systematic review and meta-analysis of randomised trials of neo-adjuvant hormone therapy for localised and locally advanced prostate carcinoma","volume":"35","author":"Shelley","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.eururo.2013.05.033_bib0285","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.juro.2008.04.012","article-title":"Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer","volume":"180","author":"Chi","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0290","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S1470-2045(06)70700-8","article-title":"Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy","volume":"7","author":"Messing","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0295","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0140-6736(11)61095-7","article-title":"Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial","volume":"378","author":"Warde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2013.05.033_bib0300","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1464-410X.2006.06648.x","article-title":"Surgically managed lymph node-positive prostate cancer: does delaying hormonal therapy worsen the outcome?","volume":"99","author":"Spiess","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0305","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.juro.2007.05.048","article-title":"Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era","volume":"178","author":"Boorjian","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0310","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.urology.2004.02.011","article-title":"Is the efficacy of hormonal therapy affected by lymph node status? Data from the bicalutamide (Casodex) early prostate cancer program","volume":"63","author":"Iversen","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.05.033_bib0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1464-410X.2005.06051.x","article-title":"Bicalutamide 150mg plus standard care vs standard care alone for early prostate cancer","volume":"97","author":"McLeod","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0320","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.ctrv.2009.05.001","article-title":"Adjuvant hormone therapy for localised and locally advanced prostate carcinoma: a systematic review and meta-analysis of randomised trials","volume":"35","author":"Shelley","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.eururo.2013.05.033_bib0325","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.eururo.2011.01.025","article-title":"EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"59","author":"Mottet","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0330","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.eururo.2011.02.024","article-title":"Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2-4 pN+ prostate cancer: results of a matched analysis","volume":"59","author":"Briganti","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0335","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.eururo.2009.01.046","article-title":"Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy","volume":"55","author":"Da Pozzo","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0340","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1159\/000339279","article-title":"Competing mortality contributes to excess mortality in patients with poor-risk lymph node-positive prostate cancer treated with radical prostatectomy","volume":"89","author":"Froehner","year":"2012","journal-title":"Urol Int"},{"key":"10.1016\/j.eururo.2013.05.033_bib0345","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.eururo.2012.08.054","article-title":"Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis","volume":"63","author":"Briganti","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2013.05.033_bib0355","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1097\/01.ju.0000143448.04161.cc","article-title":"Prognosis of patients with lymph-node positive prostate cancer following radical prostatectomy: long-term results","volume":"172","author":"Daneshmand","year":"2004","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813005009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813005009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T01:01:46Z","timestamp":1595811706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283813005009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":70,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0302283813005009"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2013.05.033","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}